Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication

Details for Australian Patent Application No. 2004298460 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Meyer, Christophe; Doublet, Frederic Marc Maurice; Timmerman, Philip Maria Martha Bern; Willebrords, Rudy Edmond; Bonfanti, Jean-Francois; Fortin, Jerome Michel Claude; Andries, Koenraad Jozef Lodewijk; Muller, Philippe; Gevers, Tom Valerius Josepha

Agent Shelston IP

Pub. Number AU-B-2004298460

PCT Pub. Number WO2005/058871

Priority 04105312.5 26.10.04 EP; 03104810.1 18.12.03 EP; 60/567,182 30.04.04 US

Filing date 20 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 19 March 2009

International Classifications

A61K 31/4184 (2006.01)

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/058871 Priority application(s): WO2005/058871

19 March 2009 Application Accepted

  Published as AU-B-2004298460

16 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004298470-Device for assembling the housing and the body of a hydraulic rock-breaker

2004298459-5or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication